Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × Mifepristone × Clear all

NCT02012296 2022-07-13

Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer

Phase 1/2 Completed

88 enrolled 14 charts

Prostatic Neoplasms